Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.45 |
| ▸ | CA7 | P43166 | 4/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 9/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1784055 | 1.00 | CA12 (0.45) | CA12CA7CA14CA1CA2 | |
| SCHEMBL32008 | 0.86 | CA12 (0.47) | CA12CA7CA14CA1CA2 | |
| SCHEMBL21178406 | 0.80 | CA12 (0.40) | CA12CA7CA14CA1CA2 | |
| SCHEMBL30471759 | 0.79 | CA12 (0.53) | CA12CA7CA14CA1CA2 | |
| SCHEMBL1787681 | 0.78 | CA12 (0.49) | CA12CA7CA14CA1CA2 | |
| SCHEMBL24120 | 0.77 | CA12 (0.48) | CA12CA7CA14CA1CA2 | |
| SCHEMBL1787459 | 0.75 | CYP11B2 (0.56) | CA12CA7CA14CA1CA2 | |
| SCHEMBL17335683 | 0.74 | ALDH1A1 (0.61) | MTNR1AMTNR1B | |
| SCHEMBL7445856 | 0.74 | ALDH1A1 (0.61) | MTNR1AMTNR1B | |
| SCHEMBL26779718 | 0.74 | ALDH1A1 (0.61) | MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2186804-B1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO (JP) | 2015-06-17 | — | — | EP | disclosed |
| US-8288393-B2 | Nitrogen-containing heterocyclic compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20110124858-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2011-05-26 | — | — | US | disclosed |
| EP-2186804-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PEST CONTROL AGENT | Nippon Soda Co., Ltd. (JP) | 2010-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124858-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PEST CONTROL AGENT | NOS1, NOS2, NOX1 | CA12 1557/4885CA7 2352/4885CA14 2269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.